Unknown

Dataset Information

0

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.


ABSTRACT: Individuals with Lynch syndrome (LS), have an increased risk of developing cancer. Common genetic variants of telomerase reverse transcriptase (TERT) have been associated with a wide range of cancers, including colorectal cancer (CRC) in LS. We combined genotype data from 1881 LS patients, carrying pathogenic variants in MLH1, MSH2 or MSH6, for rs2075786 (G>A, intronic variant), 1207 LS patients for rs2736108 (C>T, upstream variant) and 1201 LS patients for rs7705526 (C>A, intronic variant). The risk of cancer was estimated by heterozygous/homozygous odds ratio (OR) with mixed-effects logistic regression to adjust for gene/gender/country of sample origin considering family identity. The AA genotype of SNP rs2075786 is associated with 85% higher odds at developing cancer compared to GG genotype in MSH2 pathogenic variant carriers (p = 0.0160). Kaplan-Meier analysis also shows an association for rs2075786; the AA allele for MSH2 variant carriers confers risk for earlier diagnosis of LS cancer (log-rank p = 0.0011). We report a polymorphism in TERT to be a possible modifier of disease risk in MSH2 pathogenic variant carriers. The rs2075786 SNP in TERT is associated with a differential risk of developing cancer for MSH2 pathogenic variant carriers. Use of this information has the potential to personalise screening protocols for LS patients.

SUBMITTER: Wiik MU 

PROVIDER: S-EPMC8166931 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5250687 | biostudies-literature
2017-01-01 | GSE81509 | GEO
| S-EPMC3641380 | biostudies-literature
| S-EPMC4962008 | biostudies-literature
| S-EPMC7012206 | biostudies-literature
| S-EPMC8806350 | biostudies-literature
| S-EPMC2929889 | biostudies-other
| S-EPMC4714691 | biostudies-literature
| S-EPMC7530785 | biostudies-literature
2017-01-01 | GSE77146 | GEO